Armata Pharmaceuticals, Inc.
Clinical trials sponsored by Armata Pharmaceuticals, Inc., explained in plain language.
-
New drug shows promise against staph blood infections
Disease control CompletedThis study tested a new medicine called AP-SA02, given through a vein, along with standard antibiotics for adults with a Staph blood infection. The main goal was to check if the combination is safe and tolerable. Researchers also looked at whether it helped clear the infection fa…
Phase: PHASE1, PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Virus cocktail inhaled to fight Drug-Resistant lung infection
Disease control CompletedThis study tested an inhaled mixture of bacteria-killing viruses (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. Participants received either the phage therapy or a placebo by inhalation. The goal was to see if the phages could safely reduce the…
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC